Abstract
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | European Respiratory Journal |
| Vol/bind | 32 |
| Udgave nummer | 6 |
| Sider (fra-til) | 1607-15 |
| Antal sider | 9 |
| ISSN | 0903-1936 |
| DOI | |
| Status | Udgivet - 2008 |
Adgang til dokumentet
Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of TB. / Ruhwald, Morten; Bodmer, T; Maier, C; Jepsen, M; Andersen, M B; Eugen-Olsen, Jesper; Ravn, Pernille; NN, NN.
I: European Respiratory Journal, Bind 32, Nr. 6, 2008, s. 1607-15.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
}
TY - JOUR
T1 - Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of TB.
AU - Ruhwald, Morten
AU - Bodmer, T
AU - Maier, C
AU - Jepsen, M
AU - Andersen, M B
AU - Eugen-Olsen, Jesper
AU - Ravn, Pernille
AU - NN, NN
PY - 2008
Y1 - 2008
N2 - The aim of the study was to evaluate the potential of diagnostic tests based on IP-10 and MCP-2, and compare the performance with the Quantiferon-Gold In-Tube (QFT-IT) test.IP-10 and MCP-2 were determined in supernatants from whole blood stimulated with M.tuberculosis-specific antigens. Samples were obtained from 80 patients with culture and/or PCR proven TB, and 124 unexposed healthy controls; 86 high school students and 38 high school staff. IP-10 and MCP-2 test cut-offs were established based on ROC curve analysis.TB patients produced significantly higher levels of IP-10 (median 2158 pg.ml(-1)) and MCP-2 (median 379 pg.ml(-1)) compared with IFN-gamma (median 215 pg.ml(-1), p<0.0001). The QFT-IT, IP-10 and MCP-2 tests detected 81%, 83% and 71% of the TB patients; 0%, 3% and 0% of the high school students and 0%, 16%; and 3% of the staff. Agreement between tests was high >89% (kappa>0.77). By combining IP-10 and IFN-gamma tests the detection rate increased among TB patients to 90% without a significant increase in positive responders among the students.In conclusion, IP-10 and MCP-2 responses to M.tuberculosis specific antigens could be used to diagnose infection. Combining IP-10 and IFN-gamma may be a simple approach to increase the detection rate of the M.tuberculosis specific in-vitro tests.
AB - The aim of the study was to evaluate the potential of diagnostic tests based on IP-10 and MCP-2, and compare the performance with the Quantiferon-Gold In-Tube (QFT-IT) test.IP-10 and MCP-2 were determined in supernatants from whole blood stimulated with M.tuberculosis-specific antigens. Samples were obtained from 80 patients with culture and/or PCR proven TB, and 124 unexposed healthy controls; 86 high school students and 38 high school staff. IP-10 and MCP-2 test cut-offs were established based on ROC curve analysis.TB patients produced significantly higher levels of IP-10 (median 2158 pg.ml(-1)) and MCP-2 (median 379 pg.ml(-1)) compared with IFN-gamma (median 215 pg.ml(-1), p<0.0001). The QFT-IT, IP-10 and MCP-2 tests detected 81%, 83% and 71% of the TB patients; 0%, 3% and 0% of the high school students and 0%, 16%; and 3% of the staff. Agreement between tests was high >89% (kappa>0.77). By combining IP-10 and IFN-gamma tests the detection rate increased among TB patients to 90% without a significant increase in positive responders among the students.In conclusion, IP-10 and MCP-2 responses to M.tuberculosis specific antigens could be used to diagnose infection. Combining IP-10 and IFN-gamma may be a simple approach to increase the detection rate of the M.tuberculosis specific in-vitro tests.
U2 - http://dx.doi.org/10.1183/09031936.00055508
DO - http://dx.doi.org/10.1183/09031936.00055508
M3 - Journal article
VL - 32
SP - 1607
EP - 1615
JO - The European Respiratory Journal
JF - The European Respiratory Journal
SN - 0903-1936
IS - 6
ER -